This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
Discussing the potential of Pfizer's Marstacimab for the treatment of hemophilia A and B
Ticker(s): PFEWho's the expert?
Institution: Tulane University
- Professor of Medicine, Pediatrics & Pathology, Chief of Hematology & Medical Oncology, & Director of the Louisiana Center for Bleeding and Clotting Disorders at Tulane University School of Medicine.
- Currently manages 200 patients with hemophilia A and B and 60 patients with sickle cell disease.
- Research focuses on coagulation disorders; oversees an active research program that receives funding from the National Institutes of Health as well as numerous other federal and industry sources.
Interview GoalThis call will focus on the results from the Phase 3 BASIS clinical trial regarding Pfizer's Marstacimab for the treatment of hemophilia A and B.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
